Healis selected to present at key biotechnology and neuroscience investor conferences in Amsterdam, New York, and San Diego
February 12, 2024 08:00 ET
|
Healis Therapeutics
Healis' clinical program developing BoNT/A neuromodulator proteins has the potential to transform care for over 280 million patients with depression.
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
February 06, 2024 08:10 ET
|
Gallant Therapeutics
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
Digital Therapeutics Market / DTx Market is Expected to Reach $21.9 Billion | MarketsandMarkets™
February 02, 2024 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Digital Therapeutics Market / DTx market in terms of revenue was estimated to be worth $6.1 billion in 2023 and is poised to reach $21.9 billion by 2028,...
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
January 29, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Recombinant Proteins Market revenue to hit USD 9 Billion by 2035, says Research Nester
January 25, 2024 05:30 ET
|
Research Nester
New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The global recombinant proteins market size is slated to expand at ~12.80% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 9...
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
January 23, 2024 08:00 ET
|
ProPhase Labs, Inc.
Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and ProfitabilityCompany in Late-Stage Discussions with Two Additional Large Global Brands...
Titan Environmental Solutions Inc. Announces Agreement to Purchase Standard Waste Services, LLC
January 16, 2024 08:00 ET
|
Titan Environmental Solutions Inc.
Troy, MI, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Titan Environmental Solutions Inc. ("Titan" or the "Company") (OTCQB: TESI) announced today that the Company signed a Membership Interest Purchase...
Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
January 08, 2024 08:00 ET
|
Gallant Therapeutics
Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
January 04, 2024 08:00 ET
|
ProPhase Labs, Inc.
Company also plans to commercialize its BE-Smart Esophageal Cancer Test in 2024Company announces the hiring of long-time industry veteran Jed Latkin as COO to help build and manage this growth Garden...
Wugen Strengthens Executive Leadership Team with Appointment of Keith Vendola, M.D., M.B.A. as Chief Financial Officer
January 03, 2024 08:00 ET
|
Wugen
Wugen Strengthens Executive Leadership Team with the Appointment of Keith Vendola, M.D., M.B.A. as Chief Financial Officer